Australia’s Therapeutic Goods Administration (TGA) determined that Covaxin (manufactured by Bharat Biotech, India) and BBIBP-CorV (manufactured by Sinopharm, China) vaccines would be 'recognized' to establish a traveler’s vaccination status.
This recognition announced on November 1, 2021, is for travelers aged 12 and over who have been vaccinated with Covaxin and those 18 to 60 who have been immunized with BBIBP-CorV.
Read More
